UNLIMITED TURBO SHORT - ABBOTT LABORATORIES Stock

Certificat

DE000PF9N5H1

Delayed Deutsche Boerse AG 14:20:50 2024-05-23 EDT
2.78 EUR +1.46% Intraday chart for UNLIMITED TURBO SHORT - ABBOTT LABORATORIES
Current month+3.79%
1 month+7.45%
Date Price Change
24-05-23 2.78 +1.46%
24-05-22 2.74 -5.19%
24-05-21 2.89 +1.05%
24-05-20 2.86 +2.88%
24-05-17 2.78 +2.21%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 02:20 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF9N5H
ISINDE000PF9N5H1
Date issued 2021-05-04
Strike 133.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.5
Lowest since issue 0.13
Spread 0.01
Spread %0.36%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.8 USD
Average target price
125.7 USD
Spread / Average Target
+19.91%
Consensus